These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20548288)

  • 1. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice.
    Pogribny IP; Starlard-Davenport A; Tryndyak VP; Han T; Ross SA; Rusyn I; Beland FA
    Lab Invest; 2010 Oct; 90(10):1437-46. PubMed ID: 20548288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet.
    Pogribny IP; Tryndyak VP; Bagnyukova TV; Melnyk S; Montgomery B; Ross SA; Latendresse JR; Rusyn I; Beland FA
    J Hepatol; 2009 Jul; 51(1):176-86. PubMed ID: 19450891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.
    Tryndyak VP; Latendresse JR; Montgomery B; Ross SA; Beland FA; Rusyn I; Pogribny IP
    Toxicol Appl Pharmacol; 2012 Jul; 262(1):52-9. PubMed ID: 22561871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice.
    Dolganiuc A; Petrasek J; Kodys K; Catalano D; Mandrekar P; Velayudham A; Szabo G
    Alcohol Clin Exp Res; 2009 Oct; 33(10):1704-10. PubMed ID: 19572984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1.
    Meng X; Guo J; Fang W; Dou L; Li M; Huang X; Zhou S; Man Y; Tang W; Yu L; Li J
    J Biol Chem; 2016 May; 291(20):10625-34. PubMed ID: 27013659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet.
    Tryndyak VP; Ross SA; Beland FA; Pogribny IP
    Mol Carcinog; 2009 Jun; 48(6):479-87. PubMed ID: 18942116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH.
    Escutia-Gutiérrez R; Rodríguez-Sanabria JS; Monraz-Méndez CA; García-Bañuelos J; Santos-García A; Sandoval-Rodríguez A; Armendáriz-Borunda J
    Sci Rep; 2021 Jun; 11(1):11709. PubMed ID: 34083664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice.
    Jiang X; Jiang L; Shan A; Su Y; Cheng Y; Song D; Ji H; Ning G; Wang W; Cao Y
    EBioMedicine; 2018 Nov; 37():307-321. PubMed ID: 30316865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
    Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y
    Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
    Wang B; Majumder S; Nuovo G; Kutay H; Volinia S; Patel T; Schmittgen TD; Croce C; Ghoshal K; Jacob ST
    Hepatology; 2009 Oct; 50(4):1152-61. PubMed ID: 19711427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.
    Zhang T; Hu J; Wang X; Zhao X; Li Z; Niu J; Steer CJ; Zheng G; Song G
    J Hepatol; 2019 Jan; 70(1):87-96. PubMed ID: 30218679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated microRNA-199a-5p inhibits nuclear receptor corepressor 1 translation in mice with non‑alcoholic steatohepatitis.
    Zhang B; Wang R; Du J; Niu J; Zhang R; Xu S; Niu X; Zhang Q; Nan Y
    Mol Med Rep; 2014 Dec; 10(6):3080-6. PubMed ID: 25269746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA changes, activation of progenitor cells and severity of liver injury in mice induced by choline and folate deficiency.
    Tryndyak VP; Marrone AK; Latendresse JR; Muskhelishvili L; Beland FA; Pogribny IP
    J Nutr Biochem; 2016 Feb; 28():83-90. PubMed ID: 26878785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice.
    Asai A; Chou PM; Bu HF; Wang X; Rao MS; Jiang A; DiDonato CJ; Tan XD
    Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G496-504. PubMed ID: 24436353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
    Yamazaki Y; Kakizaki S; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
    J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish.
    Lai CY; Lin CY; Hsu CC; Yeh KY; Her GM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):844-856. PubMed ID: 29678641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.
    Haque JA; McMahan RS; Campbell JS; Shimizu-Albergine M; Wilson AM; Botta D; Bammler TK; Beyer RP; Montine TJ; Yeh MM; Kavanagh TJ; Fausto N
    Lab Invest; 2010 Dec; 90(12):1704-17. PubMed ID: 20548286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
    Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.